Palogic Value Management’s DocuSign DOCU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
22,517
+15,644
+228% +$733K 0.33% 87
2026
Q1
$326K Buy
6,873
+461
+7% +$23.6K 0.14% 139
2025
Q4
$439K Buy
6,412
+773
+14% +$53.5K 0.18% 117
2025
Q3
$407K Sell
5,639
-48
-0.8% -$3.7K 0.16% 123
2025
Q2
$443K Buy
5,687
+249
+5% +$20.1K 0.18% 113
2025
Q1
$443K Buy
5,438
+117
+2% +$10.2K 0.19% 109
2024
Q4
$479K Buy
5,321
+69
+1% +$5.51K 0.18% 115
2024
Q3
$326K Sell
5,252
-35
-0.7% -$1.96K 0.11% 141
2024
Q2
$283K Buy
5,287
+193
+4% +$10.9K 0.12% 127
2024
Q1
$303K Buy
5,094
+313
+7% +$17.7K 0.13% 123
2023
Q4
$284K Buy
+4,781
New +$219K 0.13% 126
2023
Q2
Sell
-3,555
Closed -$207K 163
2023
Q1
$207K Buy
+3,555
New +$212K 0.1% 146

Other funds holding DOCU

Palogic Value Management's DOCU Position: Q2 2026 in Review

Palogic Value Management increased its DocuSign (DOCU) stake by 228% in Q2 2026, buying an estimated $733K and bringing the position to 22,517 shares worth $1M. The position accounts for 0.33% of the portfolio, ranked #87.

Palogic Value Management first reported a position in DOCU in Q1 2023 and has held it in 12 quarters since. 674 funds tracked by Wall St. Rank hold DOCU as of Q2 2026.

  • Palogic Value Management held 22,517 shares of DocuSign worth $1M as of Q2 2026.
  • Palogic Value Management bought 15,644 DocuSign shares in Q2 2026, an estimated $733K.
  • DocuSign made up 0.33% of Palogic Value Management's portfolio in Q2 2026, its #87 holding.
  • Palogic Value Management first reported a position in DocuSign in Q1 2023 and has held it in 12 quarters since.
  • 674 funds tracked by Wall St. Rank held DocuSign as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.